Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to -$500000.0.

  • Bio-Techne's Gains from Investment Securities fell 15000.0% to -$500000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $19.9 million, marking a year-over-year decrease of 6280.37%. This contributed to the annual value of $9.5 million for FY2025, which is 1830.04% down from last year.
  • Bio-Techne's Gains from Investment Securities amounted to -$500000.0 in Q4 2025, which was down 15000.0% from $18.8 million recorded in Q3 2025.
  • Over the past 5 years, Bio-Techne's Gains from Investment Securities peaked at $37.6 million during Q2 2021, and registered a low of -$141.8 million during Q2 2023.
  • Its 5-year average for Gains from Investment Securities is -$240000.0, with a median of $1.2 million in 2021.
  • As far as peak fluctuations go, Bio-Techne's Gains from Investment Securities crashed by 119076.92% in 2023, and later surged by 283750.0% in 2024.
  • Quarter analysis of 5 years shows Bio-Techne's Gains from Investment Securities stood at $1.3 million in 2021, then crashed by 30.77% to $900000.0 in 2022, then skyrocketed by 44.44% to $1.3 million in 2023, then dropped by 23.08% to $1.0 million in 2024, then plummeted by 150.0% to -$500000.0 in 2025.
  • Its Gains from Investment Securities stands at -$500000.0 for Q4 2025, versus $18.8 million for Q3 2025 and $1.2 million for Q2 2025.